Kalshi schools donation lands as Second Circuit clears state suits

Kalshi donated millions to New York public schools. Attorney General Letitia James filed a subpoena petition the same week. The timing is not coincidence — it is a playbook, and New York's courts are now the stage where its limits get tested.

The Second Circuit's decision to deny Kalshi's injunction request against New York's lawsuit is the development that matters here, and it has not received the weight it deserves. The Illinois federal court's preemption injunction, which the newsroom has covered, established federal supremacy as the operative framework for one jurisdiction. The Second Circuit just held that New York's parallel litigation can proceed regardless. These two rulings are not in conflict — they are in separate courts, on separate records, with separate procedural postures — but they create a split landscape that Kalshi now has to manage simultaneously on both fronts.

The schools donation is legally irrelevant to the subpoena dispute. It is commercially rational. Kalshi raised a billion dollars at a forty billion dollar valuation, and it is spending some portion of that on the kind of goodwill that makes a state legislature hesitant to write legislation that looks like it's shutting down a company funding classrooms. That is not philanthropy. It is regulatory positioning with a charitable instrument.

The subpoena itself targets advertising claims — specifically the "no-house" framing that Kalshi uses to distinguish itself from sportsbooks. James's office has identified this as potentially deceptive under New York consumer protection law. That is the sharper legal argument, and it is one the federal preemption framework does not cleanly foreclose. CFTC authorization addresses what Kalshi can offer as a derivatives product. It does not automatically immunize how the product is described in advertising directed at New York consumers. Those are different bodies of law, with different enforcement authorities, and New York is betting that the gap between them is wide enough to survive a preemption defense.

I think New York wins more than the consensus currently expects, specifically on the advertising claims. The preemption argument that worked in Illinois rested on state law directly prohibiting CFTC-authorized contracts. A consumer protection action targeting the accuracy of marketing language sits on different ground. Courts have consistently allowed state consumer fraud enforcement to operate alongside federal product authorization — the FDA clears a drug, but states can still prosecute false advertising about it. Kalshi's legal team will argue the analogy fails because the "no-house" claim is inherent to the structure of a prediction market. That argument is thinner than it sounds, because the question is not whether the structure is accurate, but whether the description of the structure is misleading to the specific consumer the advertisement reached.